Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Markets
  • Options

Abbott Laboratories’s Options: A Look at What the Big Money is Thinking

By Benzinga Insights
June 10, 11:46 AM
Deep-pocketed investors have adopted a bullish approach towards Abbott Laboratories (NYSE:ABT), and it’s something market players shouldn’t ignore.…

ABT

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • Media
  • News
  • Top Stories

Class Action Against Abbott’s Glucerna Products Proceeds in Federal Court

By Vandana Singh
June 7, 2:17 PM
WuXi AppTec employees collaborated with China's PLA on altitude sickness drugs, raising national security concerns in the U.S. Congressional committee calls for restricting biotech ties amid ongoing scrutiny.

ABT

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
June 4, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABT

Read More
1 minute read
  • Equities
  • ETFs
  • Markets
  • Top Stories

Berkshire Hathaway, Chipotle, More NYSE Stocks Hit With Trading Halts Triggered By Technical Issues

By Piero Cingari
June 3, 10:37 AM
NYSE experiences trading halts Monday due to a technical issue. Stocks like Berkshire Hathaway and Chipotle are impacted.

ABT

Read More
4 minute read
  • Options

8 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
May 23, 1:35 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABBV

Read More
3 minute read
  • Analyst Ratings

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

By Benzinga Insights
May 22, 2:00 PM
Throughout the last three months, 5 analysts have evaluated Abbott Laboratories (NYSE:ABT), offering a diverse set of opinions…

ABT

Read More
2 minute read
  • Markets
  • Media
  • News
  • Trading Ideas

Jim Cramer Calls This Healthcare Stock A ‘Worthy Spec,’ Recommends Avoiding Canada Goose

By Avi Kapoor
May 21, 8:44 AM
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings.

ABT

Read More
3 minute read
  • Markets
  • Options

Looking At Abbott Laboratories’s Recent Unusual Options Activity

By Benzinga Insights
May 14, 1:45 PM
Whales with a lot of money to spend have taken a noticeably bearish stance on Abbott Laboratories. Looking…

ABT

Read More
2 minute read
  • Insider Trades
  • Markets
  • News
  • Pre-Market Outlook
  • Short Ideas
  • Trading Ideas

Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling

By Avi Kapoor
May 9, 8:35 AM
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders…

ABT

Read More
2 minute read
  • Short Ideas
  • Short Sellers
  • Trading Ideas

How Is The Market Feeling About Abbott Laboratories?

By Benzinga Insights
May 3, 9:15 AM
Abbott Laboratories’s (NYSE:ABT) short percent of float has fallen 7.69% since its last report. The company recently reported…

ABT

Posts pagination

1 2 … 27 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service